---
figid: PMC5514966__oncotarget-08-37974-g004
figtitle: 'Role of EZH2 in cancer stem cells: from biological insight to a therapeutic
  target'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5514966
filename: oncotarget-08-37974-g004.jpg
figlink: /pmc/articles/PMC5514966/figure/F4/
number: F4
caption: EZH2 regulates CSCs through multiple pathways, including BMP signaling, WNT/β-catenin
  signaling, AKT/EZH2/STAT3 signaling and Notch signaling. In addition, EZH2 mediates
  p16, p19 and E-cadherin silencing through H3K27me3 to maintain CSC properties. EZH2
  also directly methylates STAT3 and inhibits BMPR1B through a PRC2-independent pathway
  to regulate CSCs.
papertitle: 'Role of EZH2 in cancer stem cells: from biological insight to a therapeutic
  target.'
reftext: Yiping Wen, et al. Oncotarget. 2017 Jun 6;8(23):37974-37990.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9259582
figid_alias: PMC5514966__F4
figtype: Figure
redirect_from: /figures/PMC5514966__F4
ndex: 46e6e57e-df0c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5514966__oncotarget-08-37974-g004.html
  '@type': Dataset
  description: EZH2 regulates CSCs through multiple pathways, including BMP signaling,
    WNT/β-catenin signaling, AKT/EZH2/STAT3 signaling and Notch signaling. In addition,
    EZH2 mediates p16, p19 and E-cadherin silencing through H3K27me3 to maintain CSC
    properties. EZH2 also directly methylates STAT3 and inhibits BMPR1B through a
    PRC2-independent pathway to regulate CSCs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT3
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RAF1
  - RNASE3
  - NOTCH1
  - CTNNB1
  - EZH2
  - SET
  - MYC
  - CDKN1A
  - BMPR1B
  - EED
  - EZH1
  - SUZ12
  - CDKN2A
  - CDKN2D
  - F9
  - REG1A
  - IL23A
  - H3P13
  - H3P10
  - ITK
  - SLC22A3
  - CDH1
  - FZR1
  - Cancer
---
